
Novo Nordisk produces over 700 million insulin pens for people with diabetes per year, and Merck has a large production of injection pens used in fertility treatment.
Up to now, pens have usually been discarded and then incinerated after use, but it is a waste of resources when injection pens are thrown out with other pharmaceutical waste, and incineration incurs a climate cost.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app